AXSM
Axsome Therapeutics, Inc.
NASDAQ · Healthcare · Biotechnology · US
$206.68
−0.80%0
Insider buys (3m)
9
Insider sells (3m)
-$44.8M
Net value (3m)
-10.7%
Price return (3m)
Form 4 filings
| Date | Insider | Activity | Shares | Price |
|---|---|---|---|---|
| Sep 3, 2026 | Jacobson Mark L. · officer: Chief Operating Officer | Sale | 10,000 | $209 |
| Sep 3, 2026 | Jacobson Mark L. · officer: Chief Operating Officer | M-Exempt | 10,000 | $13 |
| Aug 7, 2026 | TABUTEAU HERRIOT · director, 10 percent owner, officer: Chief Executive Officer | Sale | 45,004 | $212 |
| Aug 7, 2026 | TABUTEAU HERRIOT · director, 10 percent owner, officer: Chief Executive Officer | M-Exempt | 4,660 | $4.95 |
| Aug 7, 2026 | TABUTEAU HERRIOT · director, 10 percent owner, officer: Chief Executive Officer | Sale | 4,660 | $214 |
| Aug 7, 2026 | TABUTEAU HERRIOT · director, 10 percent owner, officer: Chief Executive Officer | M-Exempt | 45,004 | $4.95 |
| Jul 1, 2026 | TABUTEAU HERRIOT · director, 10 percent owner, officer: Chief Executive Officer | Sale | 49,666 | $240 |
| Jul 1, 2026 | TABUTEAU HERRIOT · director, 10 percent owner, officer: Chief Executive Officer | M-Exempt | 49,666 | $4.95 |
| Jun 11, 2026 | JEFFS ROGER · director | Sale | 286 | $246 |
| Jun 10, 2026 | Saad Mark E · director | M-Exempt | 1,429 | $0.00 |
| Jun 10, 2026 | Mahony Susan · director | M-Exempt | 1,429 | $0.00 |
| Jun 10, 2026 | JEFFS ROGER · director | M-Exempt | 1,429 | $0.00 |
| Jun 10, 2026 | Coleman Mark · director | M-Exempt | 1,429 | $0.00 |
| Jun 10, 2026 | Coleman Mark · director | Sale | 643 | $249 |
| Jun 10, 2026 | Mahony Susan · director | Sale | 300 | $237 |
| Jun 9, 2026 | Mahony Susan · director | A-Award | 1,721 | $0.00 |
| Jun 9, 2026 | Coleman Mark · director | A-Award | 1,721 | $0.00 |
| Jun 9, 2026 | TABUTEAU HERRIOT · director, 10 percent owner, officer: Chief Executive Officer | M-Exempt | 49,670 | $4.95 |
| Jun 9, 2026 | TABUTEAU HERRIOT · director, 10 percent owner, officer: Chief Executive Officer | Sale | 49,670 | $241 |
| Jun 9, 2026 | Pizzie Nick · officer: Chief Financial Officer | M-Exempt | 33,000 | $3.50 |
| Jun 9, 2026 | Pizzie Nick · officer: Chief Financial Officer | Sale | 33,000 | $240 |
| Jun 9, 2026 | Saad Mark E · director | A-Award | 1,721 | $0.00 |
| Jun 9, 2026 | JEFFS ROGER · director | A-Award | 1,721 | $0.00 |
| Jun 2, 2026 | Coleman Mark · director | Sale | 6,000 | $233 |
| Jun 2, 2026 | Coleman Mark · director | Sale | 5,537 | $223 |
| May 5, 2026 | Jacobson Mark L. · officer: Chief Operating Officer | M-Exempt | 4,517 | $13 |
| May 5, 2026 | Jacobson Mark L. · officer: Chief Operating Officer | M-Exempt | 233 | $13 |
| May 5, 2026 | Jacobson Mark L. · officer: Chief Operating Officer | Sale | 233 | $228 |
| May 5, 2026 | Jacobson Mark L. · officer: Chief Operating Officer | Sale | 4,517 | $228 |
| Apr 23, 2026 | Maizel Ari · officer: Chief Commercial Officer | A-Award | 7,224 | $0.00 |
Institutional positioning
13F filings over the trailing two quarters
New 212Increased 309Reduced 305Sold out 41
| Filer | Action | Shares | Filed |
|---|---|---|---|
| BLACKROCK, INC. | Reduced | 3,912,844 | May 13, 2026 |
| BlackRock, Inc. | Reduced | 3,103,708 | Aug 7, 2026 |
| VANGUARD PORTFOLIO MANAGEMENT LLC | New Position | 2,058,170 | May 8, 2026 |
| VANGUARD PORTFOLIO MANAGEMENT LLC | Reduced | 1,983,514 | Aug 13, 2026 |
| VANGUARD CAPITAL MANAGEMENT LLC | Increased | 1,965,086 | Aug 13, 2026 |
| VANGUARD CAPITAL MANAGEMENT LLC | New Position | 1,937,752 | May 15, 2026 |
| Invesco Ltd. | Increased | 1,671,684 | Aug 14, 2026 |
| FMR LLC | Increased | 1,566,995 | May 15, 2026 |
| FMR LLC | Reduced | 1,539,163 | Aug 13, 2026 |
| PRICE T ROWE ASSOCIATES INC /MD/ | Reduced | 1,317,059 | May 15, 2026 |
| INVESCO LTD. | Increased | 1,297,678 | May 12, 2026 |
| GEODE CAPITAL MANAGEMENT, LLC | Increased | 1,162,981 | May 15, 2026 |
| WELLINGTON MANAGEMENT GROUP LLP | Reduced | 1,145,306 | May 15, 2026 |
| DEEP TRACK CAPITAL, LP | Reduced | 1,100,000 | May 15, 2026 |
| STATE STREET CORP | Increased | 986,809 | May 15, 2026 |
Insider activity from SEC Form 4; institutional positioning from 13F filings · Latest filing Sep 3, 2026